- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Positron Emission Tomography Market to Surpass USD 3.12 Billion by 2032
Growing at a CAGR of 6.23% Driven by Rising Chronic Disease Burden and Advanced Imaging Technologies
Mar. 10, 2026 at 10:20pm
Got story updates? Submit your updates here. ›
The global Positron Emission Tomography (PET) market is experiencing steady expansion as healthcare systems increasingly prioritize early disease detection and precision diagnostics. According to DelveInsight's latest analysis, the Positron Emission Tomography market was valued at USD 1,933.85 million in 2024 and is projected to reach USD 3,127.40 million by 2032, growing at a compound annual growth rate (CAGR) of 6.23% during the forecast period from 2025 to 2032.
Why it matters
The market's growth trajectory is being fueled by the rising prevalence of chronic diseases, rapid technological advancements in imaging systems, and the growing integration of PET with other diagnostic modalities. PET imaging plays a crucial role in oncology, cardiology, and neurology, where it is used for tumor detection, staging, treatment planning, and monitoring therapeutic responses.
The details
Positron emission tomography companies include General Electric Company, Bruker Corporation, Siemens Healthcare GmbH, Koninklijke Philips N.V., Canon Medical Systems Corporation, Positron Corporation, Shimadzu Corp., RefleXion, CMR Naviscan Corporation, Segami Corporation, Neusoft Medical Systems Co., Ltd., Mediso Ltd., Sofie Biosciences (PerkinElmer Inc.), United Imaging Healthcare Co., Ltd., MinFound Medical Systems Co., Ltd, MR Solutions, and others. Technological innovations such as hybrid imaging systems, total-body PET scanners, digital PET detectors, and advanced time-of-flight (TOF) technologies are further enhancing image resolution and data acquisition speed.
- The global Positron Emission Tomography (PET) market was valued at USD 1,933.85 million in 2024.
- The Positron Emission Tomography market is projected to reach USD 3,127.40 million by 2032.
The players
General Electric Company
A multinational conglomerate and one of the leading providers of Positron Emission Tomography (PET) imaging systems.
Bruker Corporation
A manufacturer of scientific instruments, including PET imaging systems, for various industries including healthcare.
Siemens Healthcare GmbH
A subsidiary of Siemens AG and a major supplier of medical imaging equipment, including PET scanners.
Koninklijke Philips N.V.
A multinational conglomerate that produces a range of medical imaging technologies, including PET/CT and PET/MRI systems.
Canon Medical Systems Corporation
A subsidiary of Canon Inc. and a provider of advanced medical imaging solutions, including PET scanners.
The takeaway
The global Positron Emission Tomography market is poised for sustained growth as healthcare systems increasingly rely on advanced imaging technologies to address the rising burden of chronic diseases. Innovations in hybrid imaging systems, digital detectors, and radiotracer development are significantly enhancing the capabilities of PET imaging, expanding its clinical applications, and improving patient outcomes.


